CClinicalTrials.gg
RecruitingNCT07523958PARA-TOURUpdated Jun 4, 2026

Paraffin Oil for Preventing Tourniquet-Related Skin Lesions in Upper Extremity Surgery

An interventional study of Paraffin Oil in Pressure Injury, Skin Lesions and Skin Injury, sponsored by Istanbul Medipol University Hospital. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-04.

Sponsored by Istanbul Medipol University Hospital · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This randomized controlled trial aims to evaluate the effectiveness of topical paraffin oil application in preventing tourniquet-related skin lesions in patients undergoing upper extremity surgery. Pneumatic tourniquets are commonly used to provide a bloodless surgical field; however, they may cause skin complications such as erythema, edema, abrasions, blisters, and burns.

In this study, adult patients undergoing elective upper extremity surgery will be randomly assigned to either an intervention group receiving topical paraffin oil application in addition to routine protective dressing or a control group receiving routine care only. Skin integrity will be assessed immediately after tourniquet removal and at 30 and 60 minutes postoperatively using standardized skin assessment criteria.

The findings of this study are expected to contribute to the development of effective, simple, and cost-efficient strategies to prevent tourniquet-related skin complications and improve patient safety and postoperative comfort.

Read the detailed description

Pneumatic tourniquets are widely used in upper extremity surgeries to provide a bloodless surgical field, allowing better visualization and surgical precision. Despite their benefits, tourniquet application may lead to various complications, particularly skin-related injuries such as erythema, edema, abrasions, blisters, and burns. These complications are often associated with pressure, friction, and prolonged application time.

Current preventive strategies include the use of protective padding materials; however, these methods do not completely eliminate the risk of skin damage. Strengthening the skin barrier using topical agents may provide an additional protective effect. Paraffin oil, known for its barrier-forming and moisturizing properties, has the potential to reduce mechanical stress and transepidermal water loss, thereby protecting the skin.

This study is designed as a prospective, two-arm, parallel-group randomized controlled trial conducted in a single center. Eligible adult patients undergoing elective upper extremity surgery will be randomly assigned to either the intervention group (paraffin oil application plus routine care) or the control group (routine care only) using a computer-generated block randomization method.

The intervention will involve the application of topical paraffin oil to the skin area where the pneumatic tourniquet will be placed before surgery. Both groups will receive standard surgical and anesthetic care according to institutional protocols.

Skin integrity will be evaluated immediately after tourniquet removal and at 30 and 60 minutes postoperatively using standardized pressure injury classification criteria. Data will be collected using structured forms, and statistical analysis will be performed to compare the incidence and severity of skin lesions between the groups.

This study aims to provide evidence on the effectiveness of a simple, low-cost, and easily applicable intervention for preventing tourniquet-related skin complications. The results may contribute to improving clinical practice guidelines and enhancing patient safety in surgical settings.

02

Conditions studied

  • Pressure Injury
  • Skin Lesions
  • Skin Injury

Browse trials for

Keywords

  • Paraffin Oil
  • Tourniquet
  • Upper Extremity Surgery
  • Skin Injury Prevention
  • Randomized Controlled Trial
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

IInclusion Criteria:

  • Age ≥18 years
  • Patients scheduled for elective upper extremity surgery requiring pneumatic tourniquet application
  • ASA physical status I-III
  • Body mass index (BMI) \<30 kg/m²
  • Ability to provide informed consent
  • Willingness to participate in the study

Exclusion Criteria:

  • Age \<18 years
  • Known dermatological disease or existing skin lesion at the tourniquet application site
  • Allergy or sensitivity to paraffin oil or related substances
  • Severe systemic disease (ASA IV or higher)
  • Obesity (BMI ≥30 kg/m²)
  • Emergency surgery
  • Patients transferred to intensive care postoperatively
  • Development of major postoperative complications (e.g., hematoma, seroma, nerve injury, significant bleeding)
  • Inability to communicate or comply with study procedures
  • Withdrawal from the study at any time
04

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
90 participants (estimated)

Study arms

  • Experimental
    Paraffin Oil Group

    Participants receive topical paraffin oil application before tourniquet placement in addition to routine protective dressing.

    Other: Paraffin Oil

  • No intervention
    Control Group

    Participants receive routine protective dressing without paraffin oil application.

Interventions

  • OtherParaffin Oil

    Topical paraffin oil is applied to the skin area before tourniquet placement.

05

What researchers measure

Primary outcomes

  1. Incidence of Tourniquet-Related Skin Injury

    The incidence of skin injury at the tourniquet application site will be assessed immediately after tourniquet removal (0 minutes) and at 30 and 60 minutes post-removal using clinical evaluation.

    Time frame: At 0, 30, and 60 minutes after tourniquet removal

Secondary outcomes

  1. Severity of Skin Injury

    The severity of skin injury at the tourniquet site will be evaluated at 0, 30, and 60 minutes after tourniquet removal using a standardized pressure injury classification system based on clinical observation.

    Time frame: At 0, 30, and 60 minutes after tourniquet removal

  2. Medical Device-Related Pressure Injury Risk Score

    The risk of pressure injuries associated with medical devices will be assessed immediately after the tourniquet is removed using a standard risk assessment scale. The medical device-related pressure injury risk assessment scale consists of 8 items, and the risk increases as the score decreases. The scale ranges from a minimum of 8 to a maximum of 27 points.

    Time frame: At 0 minutes after tourniquet removal

06

Study locations

1 of 1 sites recruiting
  • Kartal Dr. Lütfi Kırdar City Hospital Istanbul, Turkey
    Istanbul, 34760, Turkey (Türkiye)
    Recruiting
07

References and documents

Individual participant data

Plan to share: No — Individual participant data (IPD) will not be shared to protect participant confidentiality and comply with ethical regulations. Data will be used exclusively for the purposes of this study by the research team.

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07523958
Lead sponsor
Istanbul Medipol University Hospital
Collaborators
Dr. Lutfi Kirdar Kartal Training and Research Hospital, Medipol University
Responsible party
muzeyyen ataseven (PhD, RN, Assistant Professor, Istanbul Medipol University Hospital) — Principal investigator
First posted
Apr 13, 2026
Start date
Jan 12, 2026
Primary completion
Jun 2026 (estimated)
Completion
Jul 2026 (estimated)
Last update
Jun 4, 2026

Study contacts

Muzeyyen Ataseven, PhD, RN
Contact
muzeyyenataseven@hotmail.com
+90 505 229 9474

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion